Who owns LANTERN PHARMA INC?
- Ticker: LTRN
- CUSIP Number: 51654w101
Tip: Access positions for across all investors
Analyze quarterly positions in Lantern Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lantern Pharma stock
Who bought or sold LANTERN PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Empery Asset Management | 843k | $3.5M | 100% | Jun 2026 |
|
| CM Management | 500k | $2.1M | 100% | Jun 2026 |
|
| Vanguard Capital Management | 425k | $1.8M | 28% | Jun 2026 |
|
| Renaissance Technologies | 291k | $1.2M | 151% | Jun 2026 |
|
| BIOS Capital Management | 249k | $1.0M | -71% | Jun 2026 |
|
| Geode Capital Management | 103k | $429k | -8% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 50k | $208k | 1% | Jun 2026 |
|
| Citadel Advisors | 48k | $200k | 100% | Jun 2026 |
|
| Westside Investment Management | 48k | $200k | -4% | Jun 2026 |
|
| Quadrature Capital | 40k | $165k | 100% | Jun 2026 |
|
| Goss Wealth Management | 27k | $113k | -1% | Jun 2026 |
|
| Horizon Kinetics Asset Management | 25k | $105k | -5% | Jun 2026 |
|
| Davenport & Co | 24k | $99k | 0% | Jun 2026 |
|
| State Street Corporation | 24k | $32k | 0% | Mar 2026 |
|
| BlackRock | 22k | $93k | -51% | Jun 2026 |
|
| Bank of New York Mellon | 21k | $89k | 0% | Jun 2026 |
|
| Northern Trust | 18k | $73k | 12% | Jun 2026 |
|
| XTX Topco | 17k | $73k | 100% | Jun 2026 |
|
| Dimensional Fund Advisors | 17k | $70k | -56% | Jun 2026 |
|
| UBS Group | 17k | $69k | 65% | Jun 2026 |
|
| Colony | 15k | $64k | 0% | Jun 2026 |
|
| Susquehanna International | 14k | $59k | 100% | Jun 2026 |
|
| Cetera Investment Advisers | 12k | $51k | 0% | Jun 2026 |
|
| Marshall Wace | 12k | $50k | 100% | Jun 2026 |
|
| Farther Finance Advisors | 11k | $46k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 2.4k | $9.8k | 0% | Jun 2026 |
|
| Simplex Trading | 2.3k | $9.7k | 2084% | Jun 2026 |
|
| SBI Securities | 2.2k | $9.0k | 1% | Jun 2026 |
|
| Tower Research Capital | 1.2k | $4.8k | -67% | Jun 2026 |
|
| Morgan Stanley | 601.00 | $601.000000 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 500.00 | $2.1k | 0% | Jun 2026 |
|
| Entrust Financial | 500.00 | $2.1k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 220.00 | $917.004000 | 0% | Jun 2026 |
|
| UMA Financial Services | 158.00 | $659.002200 | 100% | Jun 2026 |
|
| Rialto Wealth Management | 123.00 | $512.996100 | 100% | Jun 2026 |
|
| Citigroup | 45.00 | $62.001000 | 100% | Mar 2026 |
|
| Group One Trading | 23.00 | $95.999700 | 0% | Jun 2026 |
|
| Barclays | 6.00 | $25.000200 | 100% | Jun 2026 |
|
| Key FInancial | 2.00 | $8.000000 | 0% | Jun 2026 |
|
Who sold out of Lantern Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Voss Capital | Mar 2026 | 50k | $69k |
| Curio Wealth | Mar 2026 | 2.0k | $2.7k |
| Wells Fargo & Company | Mar 2026 | 1.5k | $2.0k |
| FMR | Mar 2026 | 500.00 | $685.000000 |